Tuesday, February 09, 2016 11:21:01 PM
I've touched before on BergenBio but I find all this fascinating... and when did PPHM seem to have those back to back days of 30M shares was it? that just so happened in March of 2014 and this was about the time that ex-PPHM Longhen Zhou went from BerGenBio back over to NantBioscience (part of Nantworks..) but heck, what isn't part of Nantworks so many divisions over there.
David Micklem:
https://no.linkedin.com/in/dmicklem
James Lorens:
https://no.linkedin.com/in/james-lorens-9ab51431
https://www.researchgate.net/profile/James_Lorens
Tone Sandal
Tone Sandal serves as Vice President of Research Services at BerGenBio AS.
http://www.bloomberg.com/research/stocks/private/person.asp?personId=108457135&privcapId=107144331&previousCapId=107144331&previousTitle=BerGenBio%20AS
https://www.researchgate.net/profile/Tone_Sandal
Longhen Zhou:
Experience
Head, Preclinical Development
NantBioScience, division of NantWorks, LCC
March 2014 – Present (2 years)101 Theory Street, Irivne, CA 92617
Director, Cancer Biology
BerGenBio AS
November 2012 – February 2014 (1 year 4 months)Bergen Area, Norway
BerGenBio AS is a privately-held biotech company focused on developing first-in-class therapeutics for metastatic and drug resistant cancers by targeting the epithelial to mesenchymal transition (EMT) process in cancer cells.
Head, Principal Investigator, Preclinical Dept.
NantWorks, LLC
October 2010 – November 2012 (2 years 2 months)Costa Mesa
•Direct a research team in the discovery and development of novel personalized medicine in oncology with focus on in vivo pharmacology, PK, PD, PK/PD and toxicology studies.
•Identify and implement strategy to take molecules from early discovery efforts through
Development and IND submission.
•Serve as a project team representative as well as provide mentorship to junior scientists and research associates.
•Initiate and manage external scientific interaction, collaborations and CROs.
•Built up and manage all aspects of the state-of-the-art vivarium facility and chair animal care program.
Senior Research Scientist
Abraxis BioScience
May 2009 – October 2010 (1 year 6 months)
Preclinical Discovery & Development for both small molecules and antibody drug (ADC)
Research Scientist
Peregrine Pharmaceuticals
January 2008 – May 2009 (1 year 5 months)
Preclinical development for antibody drug
Postdoctoral Scholar
University of California, Irvine
2003 – 2008 (5 years)
Novel target-based therapy
Visiting Fellow
National Cancer Instittue, National Institutes of Health
October 2000 – December 2002 (2 years 3 months)
angiogenesis & metastasis, signal transduction
..
..
https://www.linkedin.com/in/longen-zhou-8291a26?authType=name&authToken=KyhE&trk=prof-sb-browse_map-name
----------------------
-----------------------------------------------
As an added bonus, how about former Dr. Brekken lab member Ms. Kristina, landing as scientist at BerGenBio. Travel and see the world Kristina : ) I'd like that one day....but must be patient for the PPHM breakout...
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM